Anaplastic large cell lymphoma (ALCL), ALK-positive, is a type of non-Hodgkin lymphoma characterized by the presence of anaplastic large cells. This malignancy primarily affects lymphatic tissues but can also involve extranodal sites and solid organs. Accurate coding with ICD-10 Code C84.69 is essential for proper diagnosis, documentation, billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this condition.
ICD-10 Code C84.69 represents Anaplastic large cell lymphoma, ALK-positive, affecting extranodal and solid organ sites. This code is utilized when documenting cases of ALCL that exhibit the ALK gene rearrangement, which is crucial for treatment decisions and prognosis. It should be used in clinical documentation and billing when the diagnosis is confirmed, ensuring accurate representation of the patient's condition.
Anaplastic large cell lymphoma (ALCL), ALK-positive, is a rare and aggressive form of non-Hodgkin lymphoma that arises from T-cells. The presence of the ALK gene rearrangement is a key feature that influences treatment options and prognosis. This condition can manifest in lymph nodes as well as extranodal sites, necessitating prompt medical intervention.
ICD-10 Code C84.69 is integral to SOAP notes, facilitating the documentation of symptoms, assessments, and treatment plans for patients diagnosed with Anaplastic large cell lymphoma, ALK-positive. This code supports both acute and chronic care settings, ensuring comprehensive patient management.
In SOAP notes, ICD-10 Code C84.69 connects subjective patient reports and objective clinical findings to a formal diagnosis of Anaplastic large cell lymphoma, ALK-positive. This coding ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of Anaplastic large cell lymphoma, ALK-positive, often requires hospitalization due to the aggressive nature of the disease. Treatment typically involves chemotherapy and targeted therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.69 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 85025 | Complete blood count with automated differential. |
| 77014 | Radiologic examination, lymphatic system. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Common Questions About Using ICD-10 Code C84.69 for Anaplstc lg cell lymph, ALK-pos, extrnod and solid org sites
What are the common symptoms of Anaplastic large cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and skin lesions if extranodal sites are involved.
How is Anaplastic large cell lymphoma diagnosed?
Diagnosis typically involves a biopsy of affected lymph nodes or tissues, followed by histopathological examination to identify anaplastic large cells and assess ALK status.
What treatment options are available for Anaplastic large cell lymphoma?
Treatment usually includes chemotherapy, and in some cases, targeted therapy based on ALK positivity. Supportive care is also important to manage symptoms and side effects.
Is Anaplastic large cell lymphoma curable?
While Anaplastic large cell lymphoma can be aggressive, many patients respond well to treatment, and some may achieve remission. Long-term outcomes depend on various factors, including stage and response to therapy.
Clinical Notes
SOAP notes
DAP notes
AI medical notes